Bulk Manufacturer of Controlled Substances Application: Bulk Manufacturer of Marihuana: Lily's Eden Garden Farms Corporation, 51371-51372 [2024-13216]
Download as PDF
51371
Federal Register / Vol. 89, No. 117 / Monday, June 17, 2024 / Notices
cover page and/or the first page. (See
Handbook for Electronic Filing
Procedures, Electronic Filing
Procedures 1). Please note the
Secretary’s Office will accept only
electronic filings during this time.
Filings must be made through the
Commission’s Electronic Document
Information System (EDIS, https://
edis.usitc.gov.) No in-person paperbased filings or paper copies of any
electronic filings will be accepted until
further notice. Persons with questions
regarding filing should contact the
Secretary at EDIS3Help@usitc.gov.
Any person desiring to submit a
document to the Commission in
confidence must request confidential
treatment. All such requests should be
directed to the Secretary to the
Commission and must include a full
statement of the reasons why the
Commission should grant such
treatment. See 19 CFR 201.6. Documents
for which confidential treatment by the
Commission is properly sought will be
treated accordingly. All information,
including confidential business
information and documents for which
confidential treatment is properly
sought, submitted to the Commission for
purposes of this Investigation may be
disclosed to and used: (i) by the
Commission, its employees and Offices,
and contract personnel (a) for
developing or maintaining the records
of this or a related proceeding, or (b) in
internal investigations, audits, reviews,
and evaluations relating to the
programs, personnel, and operations of
the Commission including under 5
U.S.C. Appendix 3; or (ii) by U.S.
government employees and contract
personnel,2 solely for cybersecurity
purposes. All nonconfidential written
submissions will be available for public
inspection at the Office of the Secretary
and on EDIS.3
This action is taken under the
authority of section 337 of the Tariff Act
of 1930, as amended (19 U.S.C. 1337),
and of §§ 201.10 and 210.8(c) of the
Commission’s Rules of Practice and
Procedure (19 CFR 201.10, 210.8(c)).
By order of the Commission.
Issued: June 11, 2024.
Lisa Barton,
Secretary to the Commission.
khammond on DSKJM1Z7X2PROD with NOTICES
[FR Doc. 2024–13238 Filed 6–14–24; 8:45 am]
BILLING CODE 7020–02–P
1 Handbook for Electronic Filing Procedures:
https://www.usitc.gov/documents/handbook_on_
filing_procedures.pdf.
2 All contract personnel will sign appropriate
nondisclosure agreements.
3 Electronic Document Information System
(EDIS): https://edis.usitc.gov.
VerDate Sep<11>2014
17:00 Jun 14, 2024
Jkt 262001
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
to be registered as an importer of the
following basic class(es) of controlled
substance(s):
[Docket No. DEA–1387]
Controlled substance
Importer of Controlled Substances
Application: AndersonBrecon Inc. DBA
PCI Pharma Services
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
AndersonBrecon, Inc. DBA
PCI Pharma Services has applied to be
registered as an importer of basic
class(es) of controlled substance(s).
Refer to SUPPLEMENTARY INFORMATION
listed below for further drug
information.
SUMMARY:
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before July 17, 2024. Such persons
may also file a written request for a
hearing on the application on or before
July 17, 2024.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment. All
requests for a hearing must be sent to:
(1) Drug Enforcement Administration,
Attn: Hearing Clerk/OALJ, 8701
Morrissette Drive, Springfield, Virginia
22152; and (2) Drug Enforcement
Administration, Attn: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing should
also be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.34(a), this
is notice that on May 9, 2024,
AndersonBrecon, Inc. DBA PCI Pharma
Services, 4545 Assembly Drive,
Rockford, Illinois 61109–3081, applied
DATES:
PO 00000
Frm 00072
Fmt 4703
Sfmt 4703
Tetrahydrocannabinols ....
3,4-Methylenedioxymethamphetamine.
Dimethyltryptamine ..........
Drug
code
Schedule
7370
7405
I
I
7435
I
The company plans to import the
listed controlled substances for clinical
trials. No other activities for these drug
codes are authorized for this
registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
Marsha L. Ikner,
Acting Deputy Assistant Administrator.
[FR Doc. 2024–13220 Filed 6–14–24; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. 1386]
Bulk Manufacturer of Controlled
Substances Application: Bulk
Manufacturer of Marihuana: Lily’s
Eden Garden Farms Corporation
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
The Drug Enforcement
Administration (DEA) is providing
notice of an application it has received
from an entity applying to be registered
to manufacture in bulk basic class(es) of
controlled substances listed in schedule
I. DEA intends to evaluate this and other
pending applications according to its
regulations governing the program of
growing marihuana for scientific and
medical research under DEA
registration.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before August 16, 2024.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
SUMMARY:
E:\FR\FM\17JNN1.SGM
17JNN1
khammond on DSKJM1Z7X2PROD with NOTICES
51372
Federal Register / Vol. 89, No. 117 / Monday, June 17, 2024 / Notices
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment.’’
SUPPLEMENTARY INFORMATION: The
Controlled Substances Act (CSA)
prohibits the cultivation and
distribution of marihuana except by
persons who are registered under the
CSA to do so for lawful purposes. In
accordance with the purposes specified
in 21 CFR 1301.33(a), the Drug
Enforcement Administration (DEA) is
providing notice that the entity
identified below has applied for
registration as a bulk manufacturer of
schedule I controlled substances. In
response, registered bulk manufacturers
of the affected basic class(es), and
applicants therefor, may submit
electronic comments on or objections of
the requested registration, as provided
in this notice. This notice does not
constitute any evaluation or
determination of the merits of the
application submitted.
The applicant plans to manufacture
bulk active pharmaceutical ingredients
(APIs) for product development and
distribution to DEA registered
researchers. If the application for
registration is granted, the registrant
would not be authorized to conduct
other activity under this registration
aside from those coincident activities
specifically authorized by DEA
regulations. DEA will evaluate the
application for registration as a bulk
manufacturer for compliance with all
applicable laws, treaties, and
regulations and to ensure adequate
safeguards against diversion are in
place.
As this applicant has applied to
become registered as a bulk
manufacturer of marihuana, the
application will be evaluated under the
criteria of 21 U.S.C. 823(a). DEA will
conduct this evaluation in the manner
described in the rule published at 85 FR
82333 on December 18, 2020, and
reflected in DEA regulations at 21 CFR
part 1318.
In accordance with 21 CFR
1301.33(a), DEA is providing notice that
on May 6, 2024, Lily’s Eden Garden
Farms Corporation, 1821 Waterman
VerDate Sep<11>2014
17:00 Jun 14, 2024
Jkt 262001
Road, Delhi, New York 13753, applied
to be registered as a bulk manufacturer
of the following basic class(es) of
controlled substances:
Drug
code
Controlled substance
Marihuana Extract ...........
Marihuana ........................
I
7350
7360
Schedule
I
II
Marsha L. Ikner,
Acting Deputy Assistant Administrator.
addressed to the Assistant Attorney
General, Environment and Natural
Resources Division, and should refer to
United States v. Santolubes, LLC, et al.,
24–cv–807, D.J. Ref. No. 90–11–2–417/
5. All comments must be submitted no
later than thirty (30) days after the
publication date of this notice.
Comments may be submitted either by
email or by mail:
To submit
comments:
Send them to:
By email .......
pubcomment-ees.enrd@
usdoj.gov.
Assistant Attorney General,
U.S. DOJ—ENRD, P.O.
Box 7611, Washington, DC
20044–7611.
[FR Doc. 2024–13216 Filed 6–14–24; 8:45 am]
BILLING CODE P
By mail .........
DEPARTMENT OF JUSTICE
Notice of Lodging of Proposed
Consent Decree Under the
Comprehensive Environmental
Response, Compensation, and Liability
Act
On June 10, 2024, the Department of
Justice lodged a proposed Consent
Decree with the United States District
Court for the Eastern District of Missouri
in the lawsuit entitled United States v.
Santolubes, LLC, et al., Civil Action No.
24–cv–807.
The proposed Consent Decree would
resolve claims the United States has
brought pursuant to sections 106 and
107(a) of the Comprehensive
Environmental Response,
Compensation, and Liability Act, 42
U.S.C. 9606 and 9607(a), as amended by
the Superfund Amendments and
Reauthorization Act of 1986
(‘‘CERCLA’’), regarding the Findett/
Hayford Bridge Road Groundwater
Superfund Site Operable Unit 1
(‘‘OU1’’) in St. Charles County,
Missouri.
Under the Consent Decree,
Santolubes, LLC, Santolubes
Manufacturing, LLC, and Santolubes
Spartanburg Holdings will pay $300,000
for response costs at the Sites. Of these
funds $280,000 will be deposited into a
court registry account to be transferred
either to the Environmental Protection
Agency or any parties performing work
at the Site under an agreement with the
United States. The remaining $20,000
will be transferred to EPA to perform
response actions at the Site. In
exchange, the United States and the
State will provide covenants not to sue
or to take administrative action against
Defendants pursuant to sections 106 and
107(a) of CERCLA, 42 U.S.C. 9606 and
9607(a) regarding the Site. This
settlement is based on an analysis of the
Defendant’s limited ability to pay.
The publication of this notice opens
a period for public comment on the
Consent Decree. Comments should be
PO 00000
Frm 00073
Fmt 4703
Sfmt 4703
During the public comment period,
the Consent Decree may be examined
and downloaded at this Justice
Department website: https://
www.justice.gov/enrd/consent-decrees.
If you require assistance accessing the
proposed Consent Decree, you may
request assistance by email or by mail
to the addresses provided above for
submitting comments.
Kathryn C. Macdonald,
Assistant Section Chief, Environmental
Enforcement Section, Environment and
Natural Resources Division.
[FR Doc. 2024–13204 Filed 6–14–24; 8:45 am]
BILLING CODE 4410–15–P
DEPARTMENT OF LABOR
Agency Information Collection
Activities; Submission for OMB
Review; Comment Request; Office of
Federal Contract Compliance
Programs Construction Recordkeeping
and Reporting Requirements
Notice of availability; request
for comments.
ACTION:
The Department of Labor
(DOL) is submitting this Office of
Federal Contract Compliance Programs
(OFCCP)-sponsored information
collection request (ICR) to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995
(PRA). Public comments on the ICR are
invited.
DATES: The OMB will consider all
written comments that the agency
receives on or before July 17, 2024.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
SUMMARY:
E:\FR\FM\17JNN1.SGM
17JNN1
Agencies
[Federal Register Volume 89, Number 117 (Monday, June 17, 2024)]
[Notices]
[Pages 51371-51372]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-13216]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. 1386]
Bulk Manufacturer of Controlled Substances Application: Bulk
Manufacturer of Marihuana: Lily's Eden Garden Farms Corporation
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: The Drug Enforcement Administration (DEA) is providing notice
of an application it has received from an entity applying to be
registered to manufacture in bulk basic class(es) of controlled
substances listed in schedule I. DEA intends to evaluate this and other
pending applications according to its regulations governing the program
of growing marihuana for scientific and medical research under DEA
registration.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may submit electronic comments on or
objections to the issuance of the proposed registration on or before
August 16, 2024.
ADDRESSES: The Drug Enforcement Administration requires that all
comments be submitted electronically through the Federal eRulemaking
Portal, which provides the ability to type short
[[Page 51372]]
comments directly into the comment field on the web page or attach a
file for lengthier comments. Please go to https://www.regulations.gov
and follow the online instructions at that site for submitting
comments. Upon submission of your comment, you will receive a Comment
Tracking Number. Please be aware that submitted comments are not
instantaneously available for public view on https://www.regulations.gov. If you have received a Comment Tracking Number,
your comment has been successfully submitted and there is no need to
resubmit the same comment.''
SUPPLEMENTARY INFORMATION: The Controlled Substances Act (CSA)
prohibits the cultivation and distribution of marihuana except by
persons who are registered under the CSA to do so for lawful purposes.
In accordance with the purposes specified in 21 CFR 1301.33(a), the
Drug Enforcement Administration (DEA) is providing notice that the
entity identified below has applied for registration as a bulk
manufacturer of schedule I controlled substances. In response,
registered bulk manufacturers of the affected basic class(es), and
applicants therefor, may submit electronic comments on or objections of
the requested registration, as provided in this notice. This notice
does not constitute any evaluation or determination of the merits of
the application submitted.
The applicant plans to manufacture bulk active pharmaceutical
ingredients (APIs) for product development and distribution to DEA
registered researchers. If the application for registration is granted,
the registrant would not be authorized to conduct other activity under
this registration aside from those coincident activities specifically
authorized by DEA regulations. DEA will evaluate the application for
registration as a bulk manufacturer for compliance with all applicable
laws, treaties, and regulations and to ensure adequate safeguards
against diversion are in place.
As this applicant has applied to become registered as a bulk
manufacturer of marihuana, the application will be evaluated under the
criteria of 21 U.S.C. 823(a). DEA will conduct this evaluation in the
manner described in the rule published at 85 FR 82333 on December 18,
2020, and reflected in DEA regulations at 21 CFR part 1318.
In accordance with 21 CFR 1301.33(a), DEA is providing notice that
on May 6, 2024, Lily's Eden Garden Farms Corporation, 1821 Waterman
Road, Delhi, New York 13753, applied to be registered as a bulk
manufacturer of the following basic class(es) of controlled substances:
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Marihuana Extract....................... 7350 I
Marihuana............................... 7360 I
------------------------------------------------------------------------
Marsha L. Ikner,
Acting Deputy Assistant Administrator.
[FR Doc. 2024-13216 Filed 6-14-24; 8:45 am]
BILLING CODE P